Healthcare -
Biotechnology - NASDAQ - US
$ 115.69
1.08 %
$ 11.1 B
Market Cap
75.12
P/E
SRPT - TOTAL CURRENT LIABILITIES
Total Current Liabilities SRPT - Sarepta Therapeutics, Inc.
654 M
LAST VALUE
20.16%
2 YEAR CAGR
30.35%
5 YEAR CAGR
33.64%
10 YEAR CAGR